We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Western Blotting Detection Kit

By Biotechdaily staff writers
Posted on 07 Oct 2002
A new Western Blotting Detection Kit is designed to enable scientists to visualize and identify proteins that previously went undetected due to their low concentrations.

Called ECL Advance, the kit contains the highest sensitivity chemiluminescent substrate available for the detection of immobilized protein, says the marketer, Amersham Biosciences (Little Chalfont, UK). ECL Advance is a proprietary new substrate licensed exclusively to Amersham by Lumigen, Inc. (Southfield, MI, USA). A feature called Advance Blocking Agent controls backgrounds and ensures a high level of signal intensity. Antibody concentrations can also be reduced to previously unmatched levels, allowing stocks of these potentially valuable preparations to be conserved.

‘With optimized reagents, ECL Advance offers both the highest sensitivity chemiluminescent Western blotting and the ability to reduce the concentration of antibody, thereby saving on the cost and supply of these valuable resources,” said Pieter Noordeloos, vice president marketing, proteomics, Amershambiosciences. The company says the ECL Advance is up to 10 times more sensitive than other chemiluminescent Western Blotting detection kits.




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Urine Analyzer
respons® UDS100
New
Gastrointestinal Panel
Xpert® GI Panel

Latest BioResearch News

Genetic Study Links Inherited Blindness to Gene Tied to Rare Metabolic Disorder
07 Oct 2002  |   BioResearch

Population-Scale Proteomics Study Identifies New Genetic-Protein Links
07 Oct 2002  |   BioResearch

Circulating Tumor DNA Helps Identify Targets for Personalized Immunotherapy
07 Oct 2002  |   BioResearch